Modelled testbeds: Visualizing and augmenting physical testbeds with virtual resources

Testbed facilities play a major role in the study and evolution of emerging technologies, such as those related to the Internet of Things. In this work we introduce the concept of modelled testbeds, which are 3D interactive representations of physical testbeds where the addition of virtual resources mimicking the physical ones is made possible thanks to back-end infrastructure. We present the architecture of the Syndesi testbed, deployed at the premises of University of Geneva, which was used for the prototype modelled testbed. We investigate several extrapolation techniques towards realistic value assignment for virtual sensor measurements. K-fold cross validation is performed in a dataset comprising of nearly 300’000 measurements of temperature, illuminance and humidity sensors collected from the physical sensors of the Syndesi testbed, in order to evaluate the accuracy of the methods. We obtain strong results including Mean Absolute Percentage Error (MAPE) levels below 7%

The superority of Tacrine as a supplement to Suxamethonium

No Abstrac

Microstructure of Fe Implanted Yttria stabilized zirconia studied by mössbauer spectroscopy and TEM

Single crystalline and ceramic solid solutions of (1−0.x)(ZrO2)−(0.x)(YO1.5) with x = 14−17 were implanted with high doses of Fe. Specific profile shapes were realised. The microstructure of the material before and after annealing was studied by conversion electron Mössbauer spectroscopy (CEMS), ion channeling and transmission electron microscopy (TEM). Initially Fe is present as metallic particles Fe0 and as Fe2+ and Fe3+ ions. Their relative abundancy depends on the implantation conditions. Annealing leads to complete oxidation (Fe3+) at low temperature and to the formation of microprecipitates of Fe2O3 (< 5 nm). A maximum of 4.5 × 1021 Fe cm−3 can be substitutionally incorporated for Zr. This Fe is present in a metastable state. Ion channeling and electron diffraction experiments revealed that high fluence Fe implantation does not result in amorphisation but in recrystallisation of the matrix

Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma.

RNA editing is a highly conserved posttranscriptional mechanism that contributes to transcriptome diversity. In mammals, it includes nucleobase deaminations that convert cytidine (C) into uridine (U) and adenosine (A) into inosine (I). Evidence from cancer studies indicates that RNA-editing enzymes promote certain mechanisms of tumorigenesis. On the other hand, recoding editing in mRNA can generate mutations in proteins that can participate in the Major Histocompatibility Complex (MHC) ligandome and can therefore be recognized by the adaptive immune system. Anti-cancer treatment based on the administration of immune checkpoint inhibitors enhance these natural anti-cancer immune responses. Based on RNA-Seq datasets, we evaluated the editome of melanoma cell lines generated from patients pre- and post-immunotherapy with immune checkpoint inhibitors. Our results reveal a differential editing in Arthrobacter luteus (Alu) sequences between samples pre-therapy and relapses during therapy with immune checkpoint inhibitors. These data pave the way towards the development of new diagnostics and therapies targeted to editing that could help in preventing relapses during immunotherapies

Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages.

Malaria sporozoites induce swift activation of antigen-specific CD8(+) T cells that inhibit the intracellular development of liver-stage parasites. The length of time of functional in vivo antigen presentation, estimated by monitoring the activation of antigen-specific CD8(+) T cells, is of short duration, with maximum T cell activation occurring within the first 8 h after immunization and lasting approximately 48 h. Although the magnitude of the CD8(+) T cell response closely correlates with the number of parasites used for immunization, increasing the time of antigen presentation by daily immunizations does not enhance the magnitude of this response. Thus, once a primary clonal burst is established, the CD8(+) T cell response becomes refractory or unresponsive to further antigenic stimulation. These findings strongly suggest that the most efficient strategy for the induction of primary CD8(+) T cell responses is the delivery of a maximal amount of antigen in a single dose, thereby ensuring a clonal burst that involves the largest number of precursors to become memory cells

Allergen immunotherapy on the way to product-based evaluation - a WAO statement

Allergen immunotherapy (AIT) is widely used in clinical practice for patients with moderate to severe allergic rhinitis due to inhalant allergens and may be delivered via subcutaneous (SCIT) and sublingual routes (SLIT). However, the quality of evidence for individual AIT products is very heterogeneous, and extensions of overall conclusions ("class effects") on the efficacy and disease-modifying effects to all AIT products are unjustified. In contrast, each product needs to be evaluated individually, based on available study results, to justify efficacy and specific claims on sustained and disease modifying effects per allergen and targeted patient group (children vs. adults, allergic rhinitis vs. asthma). WAO intends to support the current development to evidence-based AIT, which ultimately will lead to a more efficacious treatment of allergic patients and the appropriate recognition of AIT

HIV-Specific Cellular Immune Response Is Inversely Correlated with Disease Progression as Defined by Decline of CD4+ T Cells in Relation to HIV RNA Load

The average time between infection with human immunodeficiency virus (HIV) and development of acquired immune deficiency syndrome is ∼8 years. However, progression rates vary widely, depending on several determinants, including HIV-specific immunity, host genetic factors, and virulence of the infecting strain. In untreated HIV-infected patients with different progression rates, we examined HIV-specific T cell responses in combination with host genetic markers, such as chemokine/chemokine-receptor (CCR) polymorphisms and human leukocyte antigen (HLA) genotypes. HIV-specific CD4+ T cell responses and, to a lesser extent, HIVspecific CD8+ T cell responses were inversely correlated with progression rate. Slower progression was not related to polymorphisms in CCR genes, HLA genotype, or GB virus C coinfection. These data suggest that HIV-specific T cell responses are involved in protecting the host from disease progressio

A transformed view of cyclosporine

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/62591/1/397471a0.pd